Ultragenyx Pharmaceutical logo

Ultragenyx Pharmaceutical share price today

(RARE)

Ultragenyx Pharmaceutical share price is $43.87 & ₹3,733.12 as on 24 Dec 2024, 2.30 'hrs' IST

$43.87

-0.35

(-0.79%)

Market is closed - opens 8 PM, 24 Dec 2024

View live Ultragenyx Pharmaceutical share price in Dollar and Rupees. Guide to invest in Ultragenyx Pharmaceutical from India. Also see the sentimental analysis on Indian investors investing in Ultragenyx Pharmaceutical. Get details on the Indian mutual funds that are investing in Ultragenyx Pharmaceutical. Get Analyst recommendations and forecasts along with all the Ultragenyx Pharmaceutical's financials.

Ultragenyx Pharmaceutical share price movements

  • Today's Low: $43.00
    Today's High: $43.98

    Day's Volatility :2.23%

  • 52 Weeks Low: $37.02
    52 Weeks High: $60.37

    52 Weeks Volatility :38.68%

Ultragenyx Pharmaceutical Returns

PeriodUltragenyx Pharmaceutical Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-23.68%
-10.0%
0.0%
6 Months
10.09%
-5.7%
0.0%
1 Year
-7.87%
2.8%
0.0%
3 Years
-47.57%
-0.4%
-21.1%

Ultragenyx Pharmaceutical Key Statistics

in dollars & INR

Previous Close
$44.22
Open
$44.02
Today's High
$43.98
Today's Low
$43.0
Market Capitalization
$4.1B
Today's Volume
$644.5K
52 Week High
$60.37
52 Week Low
$37.02
Revenue TTM
$522.7M
EBITDA
$-501.1M
Earnings Per Share (EPS)
$-6.35
Profit Margin
-106.93%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-289.98%

How to invest in Ultragenyx Pharmaceutical from India?

It is very easy for Indian residents to invest directly in Ultragenyx Pharmaceutical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ultragenyx Pharmaceutical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ultragenyx Pharmaceutical or RARE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ultragenyx Pharmaceutical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ultragenyx Pharmaceutical shares which would translate to 0.019 fractional shares of Ultragenyx Pharmaceutical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ultragenyx Pharmaceutical, in just a few clicks!

Returns in Ultragenyx Pharmaceutical for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ultragenyx Pharmaceutical investment value today

Current value as on today

₹94,447

Returns

₹5,553

(-5.55%)

Returns from Ultragenyx Pharmaceutical Stock

₹7,875 (-7.87%)

Dollar Returns

₹2,322 (+2.32%)

Indian investors sentiment towards Ultragenyx Pharmaceutical

-33%

Period: Sep 24, 2024 to Dec 23, 2024. Change in 30 Days versus previous period

Search volume for Ultragenyx Pharmaceutical on INDmoney from India has reduced in the last 30 days as on Dec 24, 2024. -33% less investors are searching Ultragenyx Pharmaceutical in the last 30 days versus the previous period.

Global Institutional Holdings in Ultragenyx Pharmaceutical

  • Vanguard Group Inc

    10.77%

  • BlackRock Inc

    6.07%

  • Sands Capital Management, LLC

    5.54%

  • Wellington Management Company LLP

    4.51%

  • T. Rowe Price Associates, Inc.

    3.32%

  • Alkeon Capital Management, LLC

    3.26%

Analyst Recommendation on Ultragenyx Pharmaceutical

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 27 Wall street analysts offering stock ratings for Ultragenyx Pharmaceutical(by analysts ranked 0 to 5 stars)

Based on 27 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
24
23
23
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Ultragenyx Pharmaceutical

What analysts predicted

Upside of 111.88%

Current:

$43.87

Target:

$92.95

Insights on Ultragenyx Pharmaceutical

  • Price Movement

    In the last 3 months, RARE stock has moved down by -23.7%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 147.02M → 139.49M (in $), with an average decrease of 5.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -131.59M → -133.51M (in $), with an average decrease of 1.5% per quarter
  • RARE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 26.8% return, outperforming this stock by 34.4%
  • RARE vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 24.7% return, outperforming this stock by 72.9%
  • Price to Sales

    ForRARE every $1 of sales, investors are willing to pay $7.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Ultragenyx Pharmaceutical Technicals Summary

Sell

Neutral

Buy

Ultragenyx Pharmaceutical is currently in a neutral trading position according to technical analysis indicators.

Ultragenyx Pharmaceutical Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ultragenyx Pharmaceutical Inc.
-6.9%
10.09%
-7.87%
-47.57%
-3.05%
Regeneron Pharmaceuticals, Inc.
-4.59%
-33.24%
-15.82%
12.66%
90.77%
Biontech Se
-6.0%
34.52%
8.38%
-55.46%
241.9%
Alnylam Pharmaceuticals, Inc.
-3.47%
0.88%
26.71%
50.37%
105.71%
Vertex Pharmaceuticals Incorporated
-12.22%
-14.47%
-0.59%
82.27%
84.0%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ultragenyx Pharmaceutical Inc.
NA
NA
-0.24
-6.22
-2.9
-0.24
NA
3.76
Regeneron Pharmaceuticals, Inc.
17.36
17.36
1.04
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.04
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ultragenyx Pharmaceutical Inc.
Buy
$4.1B
-3.05%
NA
-106.93%
Regeneron Pharmaceuticals, Inc.
Buy
$77.1B
90.77%
17.36
33.61%
Biontech Se
Buy
$27.1B
241.9%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.7B
105.71%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.3B
84.0%
32.84
-4.51%

Ultragenyx Pharmaceutical Dividend announcements

  • Ultragenyx Pharmaceutical Earnings

    Ultragenyx Pharmaceutical’s price-to-earnings ratio stands at None

    Read More

About Ultragenyx Pharmaceutical

ultragenyx is a clinical-stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating metabolic genetic diseases. founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies. our company is led by an experienced management team in rare disease therapeutics. recognizing that our primary responsibility is to our patients, we are working with advocacy groups to provide support and outreach to individuals and families affected by these disorders and engage them in the clinical testing process. we are also working with regulatory agencies to design and conduct high quality clinical studies that meet the requirements for approval. we are creating an improved model for successful rare disease d
Organization
Ultragenyx Pharmaceutical
Employees
1276
CEO
Dr. Emil D. Kakkis M.D., Ph.D.
Industry
Health Technology

Management People of Ultragenyx Pharmaceutical

NameTitle
Dr. Emil D. Kakkis M.D., Ph.D.
Founder, President, CEO & Director
Mr. Howard Horn
Executive VP of Corporate Strategy & CFO
Ms. Karah Herdman Parschauer J.D.
Chief Legal Officer & Executive VP of Corporate Affairs
Mr. John Richard Pinion II
Chief Quality Operations Officer & Executive VP of Translational Sciences
Mr. Erik Harris M.B.A.
Executive VP & Chief Commercial Officer
Mr. Theodore A. Huizenga
Senior VP, Corporate Controller & Principal Accounting Officer
Mr. Ernie W. Meyer
Chief Human Resources Officer & Executive VP
Mr. Thomas R. Kassberg
Chief Business Officer & Executive VP
Mr. Vimal Srivastava
Senior Vice President of Business Development & Alliance Management
Mr. Dennis Karl Huang
Chief Technical Operations Officer and Executive VP of Gene Therapy Research & Development

Important FAQs about investing in Ultragenyx Pharmaceutical from India :

What is Ultragenyx Pharmaceutical share price today?

Ultragenyx Pharmaceutical share price today stands at $43.87, Open: $44.02 ; Previous Close: $44.22 ; High: $43.98 ; Low: $43.00 ; 52 Week High: $60.37 ; 52 Week Low: $37.02. The stock opens at $44.02, after a previous close of $44.22. The stock reached a daily high of $43.98 and a low of $43.00, with a 52-week high of $60.37 and a 52-week low of $37.02.

Can Indians buy Ultragenyx Pharmaceutical shares?

Yes, Indians can invest in the Ultragenyx Pharmaceutical (RARE) from India.

With INDmoney, you can buy Ultragenyx Pharmaceutical at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ultragenyx Pharmaceutical at zero transaction cost.

How can I buy Ultragenyx Pharmaceutical shares from India?

It is very easy to buy Ultragenyx Pharmaceutical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ultragenyx Pharmaceutical be purchased?

Yes, you can buy fractional shares of Ultragenyx Pharmaceutical with INDmoney app.

What are the documents required to start investing in Ultragenyx Pharmaceutical stocks?

To start investing in Ultragenyx Pharmaceutical, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ultragenyx Pharmaceutical

Today’s highest price of Ultragenyx Pharmaceutical (RARE) is $43.98.

Today’s lowest price of Ultragenyx Pharmaceutical (RARE) is $43.00.

What is today's market capitalisation of Ultragenyx Pharmaceutical

Today's market capitalisation of Ultragenyx Pharmaceutical RARE is 4.1B

What is the 52 Week High and Low Range of Ultragenyx Pharmaceutical

  • 52 Week High

    $60.37

  • 52 Week Low

    $37.02

What are the historical returns of Ultragenyx Pharmaceutical?

  • 1 Month Returns

    -6.9%

  • 3 Months Returns

    10.09%

  • 1 Year Returns

    -7.87%

  • 5 Years Returns

    -3.05%

Who is the Chief Executive Officer (CEO) of Ultragenyx Pharmaceutical

Dr. Emil D. Kakkis M.D., Ph.D. is the current Chief Executive Officer (CEO) of Ultragenyx Pharmaceutical.